What is DaVita Inc.?
provides kidney dialysis services for patients suffering from chronic kidney failure in the United States.
0I7E · Verdict
Moderate reward · elevated risk
0I7E's standout is cash flow; valuation and balance sheet weigh on the picture.
Based on 88% data coverage
0I7E · Verdict
10% free-cash-flow margin
Below average
Interest covered 3.5×
Model-based scoring. For information only — not financial advice.
provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. The company is listed on the LSE in UK, and a P/E ratio of 0.2x.
The scoring profile indicates limited reward potential at this time, with growth and profitability offering the most support. Risk indicators are elevated — volatility and macro sensitivity warrant consideration.
For informational purposes only. Not financial advice.